Published in Infect Immun on October 01, 1991
Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice. J Clin Invest (2003) 3.57
On the role of macrophages in anthrax. Proc Natl Acad Sci U S A (1993) 3.34
Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med (2009) 2.93
Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun (2001) 2.67
Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation. EMBO J (2000) 2.66
Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev (2004) 2.60
Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol (2005) 2.45
Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc Natl Acad Sci U S A (2009) 2.22
Bacillus anthracis pXO1 plasmid sequence conservation among closely related bacterial species. J Bacteriol (2002) 2.11
Global effects of virulence gene regulators in a Bacillus anthracis strain with both virulence plasmids. Infect Immun (2003) 2.05
Characterization of the Bacillus anthracis S-layer: cloning and sequencing of the structural gene. J Bacteriol (1995) 2.01
Polymorphism in the collagen-like region of the Bacillus anthracis BclA protein leads to variation in exosporium filament length. J Bacteriol (2003) 1.99
Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature (2010) 1.95
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Role of toxin functional domains in anthrax pathogenesis. Infect Immun (2000) 1.93
Role of pore-forming toxins in bacterial infectious diseases. Microbiol Mol Biol Rev (2013) 1.91
Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol Biol Cell (1992) 1.86
The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature. J Bacteriol (1994) 1.85
Anthrax lethal toxin induces endothelial barrier dysfunction. Am J Pathol (2005) 1.81
Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun (1995) 1.81
Anthrax spores make an essential contribution to vaccine efficacy. Infect Immun (2002) 1.62
Norepinephrine increases blood pressure but not survival with anthrax lethal toxin in rats. Crit Care Med (2009) 1.60
Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol Med (1994) 1.60
Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax. Infect Immun (2006) 1.59
Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect Immun (1999) 1.58
Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis. PLoS Negl Trop Dis (2015) 1.51
Bacillus anthracis IsdG, a heme-degrading monooxygenase. J Bacteriol (2006) 1.51
Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages. Infect Immun (2004) 1.47
Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope. J Bacteriol (2005) 1.46
Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infect Immun (2006) 1.45
Contribution of ExsFA and ExsFB proteins to the localization of BclA on the spore surface and to the stability of the bacillus anthracis exosporium. J Bacteriol (2005) 1.42
Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci U S A (2005) 1.38
Role of the protective antigen octamer in the molecular mechanism of anthrax lethal toxin stabilization in plasma. J Mol Biol (2010) 1.36
Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect Immun (1999) 1.32
The capsule and S-layer: two independent and yet compatible macromolecular structures in Bacillus anthracis. J Bacteriol (1998) 1.30
Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis. PLoS One (2008) 1.29
Bacillus anthracis physiology and genetics. Mol Aspects Med (2009) 1.29
Key tissue targets responsible for anthrax-toxin-induced lethality. Nature (2013) 1.28
Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen. Infect Immun (1999) 1.26
Differential influence of the two Bacillus anthracis plasmids on regulation of virulence gene expression. Infect Immun (1996) 1.24
Characterization of the operon encoding the alternative sigma(B) factor from Bacillus anthracis and its role in virulence. J Bacteriol (2000) 1.23
Autogenous regulation of the Bacillus anthracis pag operon. J Bacteriol (1999) 1.22
Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody. Infect Immun (2009) 1.22
An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin. Infect Immun (2005) 1.20
Monoclonal antibody therapies against anthrax. Toxins (Basel) (2011) 1.19
Identification of the Bacillus anthracis (gamma) phage receptor. J Bacteriol (2005) 1.17
Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine. Infect Immun (2004) 1.16
Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc Natl Acad Sci U S A (2003) 1.16
Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol (2011) 1.16
The adenylyl cyclase activity of anthrax edema factor. Mol Aspects Med (2009) 1.15
New insights into the biological effects of anthrax toxins: linking cellular to organismal responses. Microbes Infect (2011) 1.14
Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding. Proc Natl Acad Sci U S A (2009) 1.14
Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen. Infect Immun (1999) 1.14
Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity (2011) 1.14
BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis. Mol Microbiol (2009) 1.14
Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect Immun (2008) 1.14
CapE, a 47-amino-acid peptide, is necessary for Bacillus anthracis polyglutamate capsule synthesis. J Bacteriol (2005) 1.13
The global regulator CodY regulates toxin gene expression in Bacillus anthracis and is required for full virulence. Infect Immun (2009) 1.12
Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens. Infect Immun (2003) 1.11
Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy. Am J Respir Crit Care Med (2006) 1.08
Anthrax vaccination strategies. Mol Aspects Med (2009) 1.08
Gram-positive and gram-negative bacterial toxins in sepsis: a brief review. Virulence (2013) 1.08
Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4. Infect Immun (2006) 1.06
Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis. Infect Immun (2011) 1.06
Capsule anchoring in Bacillus anthracis occurs by a transpeptidation reaction that is inhibited by capsidin. Mol Microbiol (2008) 1.06
Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. Infect Immun (2008) 1.06
Anthrax and the inflammasome. Microbes Infect (2011) 1.06
Anthrax lethal toxin impairs IL-8 expression in epithelial cells through inhibition of histone H3 modification. PLoS Pathog (2009) 1.04
Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor. J Med Chem (2009) 1.04
Identification of a second collagen-like glycoprotein produced by Bacillus anthracis and demonstration of associated spore-specific sugars. J Bacteriol (2005) 1.03
Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism. PLoS One (2010) 1.03
Cell surface-exposed tetanus toxin fragment C produced by recombinant Bacillus anthracis protects against tetanus toxin. Infect Immun (1999) 1.01
Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines. Infect Immun (2003) 1.00
Bacillus anthracis phospholipases C facilitate macrophage-associated growth and contribute to virulence in a murine model of inhalation anthrax. Infect Immun (2006) 1.00
Anthrax lethal factor and edema factor act on conserved targets in Drosophila. Proc Natl Acad Sci U S A (2006) 1.00
The tubulin-like RepX protein encoded by the pXO1 plasmid forms polymers in vivo in Bacillus anthracis. J Bacteriol (2009) 0.96
Pathophysiology of anthrax. Front Biosci (Landmark Ed) (2009) 0.96
Differential contribution of Bacillus anthracis toxins to pathogenicity in two animal models. Infect Immun (2012) 0.96
Death at Sverdlovsk: what have we learned? Am J Pathol (1994) 0.96
Edema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages. PLoS Pathog (2007) 0.96
Anthrax edema toxin induces maturation of dendritic cells and enhances chemotaxis towards macrophage inflammatory protein 3beta. Infect Immun (2009) 0.95
Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors. Infect Immun (1999) 0.94
A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen. Proc Natl Acad Sci U S A (2003) 0.93
Oral spore vaccine based on live attenuated nontoxinogenic Bacillus anthracis expressing recombinant mutant protective antigen. Infect Immun (2005) 0.93
Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines. J Infect Dis (2012) 0.92
Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening. J Chem Inf Model (2009) 0.92
RAB11-mediated trafficking in host-pathogen interactions. Nat Rev Microbiol (2014) 0.92
Injection of Staphylococcus aureus EDIN by the Bacillus anthracis protective antigen machinery induces vascular permeability. Infect Immun (2009) 0.92
Antidotes to anthrax lethal factor intoxication. Part 1: Discovery of potent lethal factor inhibitors with in vivo efficacy. Bioorg Med Chem Lett (2010) 0.91
Domain flexibility modulates the heterogeneous assembly mechanism of anthrax toxin protective antigen. J Mol Biol (2011) 0.91
Anthrax lethal toxin disrupts the endothelial permeability barrier through blocking p38 signaling. J Cell Physiol (2012) 0.90
Identification of CodY targets in Bacillus anthracis by genome-wide in vitro binding analysis. J Bacteriol (2013) 0.89
Histopathology in a murine model of anthrax. Int J Exp Pathol (2006) 0.88
B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model. Am J Physiol Heart Circ Physiol (2013) 0.88
Mouse monoclonal antibodies to anthrax edema factor protect against infection. Infect Immun (2011) 0.88
Cationic polyamines inhibit anthrax lethal factor protease. BMC Pharmacol (2006) 0.88
The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock. Toxins (Basel) (2011) 0.88
Bacillus anthracis edema factor substrate specificity: evidence for new modes of action. Toxins (Basel) (2012) 0.87
Concerted action of sphingomyelinase and non-hemolytic enterotoxin in pathogenic Bacillus cereus. PLoS One (2013) 0.87
Development of a comprehensive, validated pharmacophore hypothesis for anthrax toxin lethal factor (LF) inhibitors using genetic algorithms, Pareto scoring, and structural biology. J Chem Inf Model (2012) 0.86
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67
Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci U S A (1982) 10.36
Demonstration of a capsule plasmid in Bacillus anthracis. Infect Immun (1985) 8.46
Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III. Gene (1983) 8.32
Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem (1986) 5.86
Evidence for plasmid-mediated toxin production in Bacillus anthracis. Infect Immun (1983) 5.69
Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillus anthracis. J Bacteriol (1962) 5.19
Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun (1986) 3.78
Purification of factor I and recognition of a third factor of the anthrax toxin. J Gen Microbiol (1961) 3.75
Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid. J Gen Microbiol (1985) 3.64
Elaboration of Bacillus anthracis antigens in a new, defined culture medium. Infect Immun (1983) 3.14
Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene (1988) 3.10
Production and purification of anthrax toxin. Methods Enzymol (1988) 3.04
Shuttle vectors containing a multiple cloning site and a lacZ alpha gene for conjugal transfer of DNA from Escherichia coli to gram-positive bacteria. Gene (1991) 3.00
Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 2.86
Construction and characterization of a protective antigen-deficient Bacillus anthracis strain. Mol Microbiol (1990) 2.67
Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. Gene (1989) 2.24
Purification and properties of in vitro-produced anthrax toxin components. J Bacteriol (1968) 2.18
Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb Pathog (1988) 2.03
Anthrax: the disease in relation to vaccines. Vaccine (1984) 1.99
Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb Pathog (1988) 1.98
Interaction of Bordetella pertussis adenylate cyclase with calmodulin. Identification of two separated calmodulin-binding domains. J Biol Chem (1988) 1.97
Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli. Gene (1988) 1.86
Anthrax toxic complex. Fed Proc (1967) 1.84
Structural homology between virulence-associated bacterial adenylate cyclases. Gene (1988) 1.62
Pathophysiological changes in the rat associated with anthrax toxin. J Infect Dis (1968) 1.30
Characterization of ATP and calmodulin-binding properties of a truncated form of Bacillus anthracis adenylate cyclase. Biochemistry (1990) 0.98
Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases. Microbiol Rev (1987) 0.98
Structure and composition of the Bacillus anthracis capsule. J Bacteriol (1965) 0.92
Comparative genomics of Listeria species. Science (2001) 12.94
In vitro model of penetration and intracellular growth of Listeria monocytogenes in the human enterocyte-like cell line Caco-2. Infect Immun (1987) 11.24
Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev (2001) 10.41
Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect Immun (1986) 10.02
Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl Environ Microbiol (2000) 7.87
Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive cocci. Cell (1991) 7.17
L. monocytogenes-induced actin assembly requires the actA gene product, a surface protein. Cell (1992) 7.15
Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect Immun (1987) 6.47
Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun (1989) 5.04
Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun (1998) 4.44
hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol (1999) 3.99
Identification of streptococci to species level by sequencing the gene encoding the manganese-dependent superoxide dismutase. J Clin Microbiol (1998) 3.84
Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J (2000) 3.83
Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol (1999) 3.49
Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett (1999) 3.00
Electron microscopic evidence for in vivo extracellular localization of Yersinia pseudotuberculosis harboring the pYV plasmid. Infect Immun (1990) 2.95
Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity. J Immunol (1987) 2.90
Attenuated mutants of the intracellular bacterium Listeria monocytogenes obtained by single amino acid substitutions in listeriolysin O. Mol Microbiol (1990) 2.68
Construction and characterization of a protective antigen-deficient Bacillus anthracis strain. Mol Microbiol (1990) 2.67
Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation. EMBO J (2000) 2.66
Invasin production by Yersinia pestis is abolished by insertion of an IS200-like element within the inv gene. Infect Immun (1996) 2.64
Molecular characterization of Bacillus strains involved in outbreaks of anthrax in France in 1997. J Clin Microbiol (1998) 2.51
A novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae. Antimicrob Agents Chemother (1998) 2.45
Purification and characterization of an extracellular 29-kilodalton phospholipase C from Listeria monocytogenes. Infect Immun (1991) 2.41
Identification and characterization of Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pXO1 and pXO2 and chromosomal DNA. FEMS Microbiol Lett (1996) 2.34
Fate of germinated Bacillus anthracis spores in primary murine macrophages. Mol Microbiol (2001) 2.30
The atxA gene product activates transcription of the anthrax toxin genes and is essential for virulence. Mol Microbiol (1995) 2.22
The incompatibility between the PlcR- and AtxA-controlled regulons may have selected a nonsense mutation in Bacillus anthracis. Mol Microbiol (2001) 2.20
The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes. Mol Microbiol (2000) 2.18
Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis. Mol Microbiol (1999) 2.12
A technique for integrating any DNA fragment into the chromosome of Escherichia coli. Gene (1984) 2.11
Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum beta-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol (1998) 2.10
Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria. Infect Immun (1994) 2.04
Emergence of vancomycin resistance in the genus Streptococcus: characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob Agents Chemother (1997) 2.03
Evaluation of tuberculosis transmission in a community by 1 year of systematic typing of Mycobacterium tuberculosis clinical isolates. J Clin Microbiol (1996) 2.03
Characterization of the Bacillus anthracis S-layer: cloning and sequencing of the structural gene. J Bacteriol (1995) 2.01
The wall peptidoglycans of Neisseria perflava, Moraxella glucidolytica, Pseudomonas alcaligenes and Proteus vulgaris strain P18. Eur J Biochem (1973) 1.99
Evaluation of CHROMagar Staph. aureus, a new chromogenic medium, for isolation and presumptive identification of Staphylococcus aureus from human clinical specimens. J Clin Microbiol (2000) 1.99
Molecular characterization of the Bacillus anthracis main S-layer component: evidence that it is the major cell-associated antigen. Mol Microbiol (1997) 1.96
Role of toxin functional domains in anthrax pathogenesis. Infect Immun (2000) 1.93
OppA of Listeria monocytogenes, an oligopeptide-binding protein required for bacterial growth at low temperature and involved in intracellular survival. Infect Immun (2000) 1.90
The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature. J Bacteriol (1994) 1.85
Dendritic cells are early cellular targets of Listeria monocytogenes after intestinal delivery and are involved in bacterial spread in the host. Cell Microbiol (2001) 1.81
Protective immunity induced by Bacillus anthracis toxin-deficient strains. Infect Immun (1995) 1.81
Identification of a ClpC ATPase required for stress tolerance and in vivo survival of Listeria monocytogenes. Mol Microbiol (1996) 1.81
The autolysin Ami contributes to the adhesion of Listeria monocytogenes to eukaryotic cells via its cell wall anchor. Mol Microbiol (2001) 1.80
Reduced virulence of a Listeria monocytogenes phospholipase-deficient mutant obtained by transposon insertion into the zinc metalloprotease gene. Infect Immun (1992) 1.79
Toxins of Bacillus anthracis. Toxicon (2001) 1.74
Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest (1983) 1.70
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group. J Antimicrob Chemother (1996) 1.66
Identification of Fusarium species involved in human infections by 28S rRNA gene sequencing. J Clin Microbiol (1999) 1.63
Characterization of superoxide dismutase genes from gram-positive bacteria by polymerase chain reaction using degenerate primers. FEMS Microbiol Lett (1995) 1.62
Structural homology between virulence-associated bacterial adenylate cyclases. Gene (1988) 1.62
The ClpC ATPase of Listeria monocytogenes is a general stress protein required for virulence and promoting early bacterial escape from the phagosome of macrophages. Mol Microbiol (1998) 1.61
Transcriptional activation of virulence genes in wild-type strains of Listeria monocytogenes in response to a change in the extracellular medium composition. Res Microbiol (1996) 1.59
Production of thiol-dependent haemolysins by Listeria monocytogenes and related species. J Gen Microbiol (1989) 1.55
The inlAB locus mediates the entry of Listeria monocytogenes into hepatocytes in vivo. J Exp Med (1996) 1.55
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for fast and accurate identification of clinically relevant Aspergillus species. Clin Microbiol Infect (2011) 1.55
The Ba813 chromosomal DNA sequence effectively traces the whole Bacillus anthracis community. J Appl Microbiol (1999) 1.49
Detection of Mycobacterium paratuberculosis by polymerase chain reaction in children with Crohn's disease. J Infect Dis (1994) 1.46
Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol (2012) 1.45
Identification of new genes involved in the virulence of Listeria monocytogenes by signature-tagged transposon mutagenesis. Infect Immun (2001) 1.44
Construction of Bacillus anthracis mutant strains producing a single toxin component. J Gen Microbiol (1993) 1.43
Granulocyte-associated immunoglobulins in renal transplant recipients with cytomegalovirus infection. Lancet (1988) 1.43
[Severe respiratory syncytial virus infections. Study of 87 infants hospitalized in an epidemic]. Arch Fr Pediatr (1989) 1.41
Mechanism of colicin E3 production in strains harboring wild-type or mutant plasmids. J Bacteriol (1978) 1.39
ClpE, a novel member of the HSP100 family, is involved in cell division and virulence of Listeria monocytogenes. Mol Microbiol (1999) 1.38
Age variation in the association between angiographic coronary disease and angina from the Coronary Artery Surgery Study (CASS) Int J Cardiol (1989) 1.37
AtxA activates the transcription of genes harbored by both Bacillus anthracis virulence plasmids. FEMS Microbiol Lett (1997) 1.37
Listeriolysin O-dependent activation of endothelial cells during infection with Listeria monocytogenes: activation of NF-kappa B and upregulation of adhesion molecules and chemokines. Mol Microbiol (1999) 1.34
CtsR controls class III heat shock gene expression in the human pathogen Listeria monocytogenes. Mol Microbiol (2000) 1.33
The zinc metalloprotease of Listeria monocytogenes is required for maturation of phosphatidylcholine phospholipase C: direct evidence obtained by gene complementation. Infect Immun (1993) 1.32
Molecular tools for the study of transcriptional regulation in Bacillus anthracis. Res Microbiol (1996) 1.32
The BtuB group col plasmids and homology between the colicins they encode. J Bacteriol (1982) 1.31
The capsule and S-layer: two independent and yet compatible macromolecular structures in Bacillus anthracis. J Bacteriol (1998) 1.30
Growth of Yersinia pseudotuberculosis in mouse spleen despite loss of a virulence plasmid of mol. wt 47 X 10(6). J Med Microbiol (1984) 1.29
Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages. Int J Med Microbiol (2000) 1.27
Optimization of green fluorescent protein expression vectors for in vitro and in vivo detection of Listeria monocytogenes. Res Microbiol (2000) 1.26
Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol (1993) 1.26
Differential influence of the two Bacillus anthracis plasmids on regulation of virulence gene expression. Infect Immun (1996) 1.24
The vacuolar ATPase proton pump is required for the cytotoxicity of Bacillus anthracis lethal toxin. FEBS Lett (1996) 1.24
Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis (2000) 1.24
IkappaBepsilon-deficient mice: reduction of one T cell precursor subspecies and enhanced Ig isotype switching and cytokine synthesis. J Immunol (1999) 1.24
MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin Microbiol Infect (2011) 1.23
In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. Antimicrob Agents Chemother (1995) 1.23
Comparison of CHROMagar Salmonella medium and hektoen enteric agar for isolation of salmonellae from stool samples. J Clin Microbiol (1999) 1.22
Comprehensive study of the intestinal stage of listeriosis in a rat ligated ileal loop system. Infect Immun (1998) 1.20
Regulation of pag gene expression in Bacillus anthracis: use of a pag-lacZ transcriptional fusion. FEMS Microbiol Lett (1992) 1.17
ClpC ATPase is required for cell adhesion and invasion of Listeria monocytogenes. Infect Immun (2000) 1.15
Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen. Infect Immun (1999) 1.14
Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children. Pediatr Infect Dis J (1996) 1.13
Adjuvant activity in delayed hypersensitivity of the peptidic part of bacterial peptidoglycans. Nature (1974) 1.12
Characterization of the Tn916-like transposon Tn3872 in a strain of abiotrophia defectiva (Streptococcus defectivus) causing sequential episodes of endocarditis in a child. Antimicrob Agents Chemother (2000) 1.12
Identification in Listeria monocytogenes of MecA, a homologue of the Bacillus subtilis competence regulatory protein. J Bacteriol (2000) 1.12
Bacillus anthracis pXO1 virulence plasmid encodes a type 1 DNA topoisomerase. Mol Microbiol (1994) 1.10
Loss of catalase activity in Tn1545-induced mutants does not reduce growth of Listeria monocytogenes in vivo. Infect Immun (1989) 1.10
Molecular characterization and expression analysis of the superoxide dismutase gene from Streptococcus agalactiae. Gene (1997) 1.10
Adjuvant activity of bacterial peptidoglycans on the production of delayed hypersensitivity and on antibody response. Eur J Immunol (1974) 1.09
Molecular epidemiology of Streptococcus pyogenes in an area where acute pharyngotonsillitis is endemic. J Clin Microbiol (1997) 1.09